Advocating for IBD Coverage Policy in Delaware
GrantID: 11876
Grant Funding Amount Low: $50,000
Deadline: Ongoing
Grant Amount High: $70,000
Summary
Grant Overview
Policy Advocacy Needs in Delaware
In Delaware, patients suffering from inflammatory bowel disease (IBD) face considerable barriers to accessing necessary treatments and medications. Recent reports indicate that 30% of IBD patients in Delaware experience difficulties obtaining the medical care they need due to gaps in insurance coverage. This makes it vital for advocacy efforts to focus on policy changes that enhance coverage for treatment, ensuring equitable healthcare access for all patients.
Who is Affected Locally
Delaware's healthcare landscape is characterized by its small size and high population density, leading to significant challenges in meeting the healthcare needs of IBD patients. Individuals from low-income backgrounds or those without comprehensive insurance plans are disproportionately affected by treatment gaps. The current policy environment limits access to innovative therapies, thus exacerbating health inequities within the state.
Bridging Coverage Gaps
The Research Fellowship Awards are designed to support initiatives that advocate for policy changes in coverage relating to IBD treatments in Delaware. The goal is to amplify the voices of local patients and healthcare providers by collaborating with lawmakers and stakeholders to highlight the critical need for improved insurance policies. This funding provides a vital opportunity to replace outdated practices with policies that recognize the complexities of IBD comprehensively.
Implementation Approach
Delaware's advocacy initiatives will focus on creating a collaborative network involving healthcare providers, advocacy groups, and patients to effectively communicate the necessity for policy changes. Research funded by these fellowships will explore existing barriers and analyze how similar states have successfully implemented improved coverage. The combined effort aims to lay the groundwork for sustainable changes that enhance equity in access to essential IBD treatments.
Eligible Regions
Interests
Eligible Requirements
